Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02737891
What this trial is testing

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Saniona 60
Testing effectiveness (Phase 2)Study completedNCT02206152
What this trial is testing

Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia Unawareness
University of Minnesota 22
Large-scale testing (Phase 3)Study completedNCT02597049
What this trial is testing

Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 424
Testing effectiveness (Phase 2)Ended earlyNCT01752985
What this trial is testing

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bristol-Myers Squibb 319
Testing effectiveness (Phase 2)Study completedNCT02798250
What this trial is testing

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 11
Testing effectiveness (Phase 2)Study completedNCT01725126
What this trial is testing

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Who this might be right for
Obesity
GlaxoSmithKline 53
Large-scale testing (Phase 3)Study completedNCT00551876
What this trial is testing

Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Type 2
Organon and Co 214
Testing effectiveness (Phase 2)Study completedNCT00502515
What this trial is testing

Dose-effect of SSR180575 in Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathies
Sanofi 309
Testing effectiveness (Phase 2)Looking for participantsNCT07298408
What this trial is testing

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Who this might be right for
Diabetic Peripheral Neuropathic Pain (DPN)Diabetic Neuropathies
Florida A&M University 20
Early research (Phase 1)Study completedNCT05754424
What this trial is testing

AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 2
Arecor Limited 41
Post-approval studies (Phase 4)Study completedNCT00333723
What this trial is testing

AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 245
Large-scale testing (Phase 3)Looking for participantsNCT07794579
What this trial is testing

Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Who this might be right for
OverweightPrediabetic StatePrehypertension+1 more
Eli Lilly and Company 2,001
Early research (Phase 1)Study completedNCT01664624
What this trial is testing

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 40
Not applicableStudy completedNCT02307279
What this trial is testing

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

Who this might be right for
OverweightObesity
Gelesis, Inc. 436
Testing effectiveness (Phase 2)Study completedNCT00703482
What this trial is testing

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Who this might be right for
Patients With Type 2 Diabetes
Solvay Pharmaceuticals 278
Large-scale testing (Phase 3)Study completedNCT00661362
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 570
Large-scale testing (Phase 3)Study completedNCT02558296
What this trial is testing

Bexagliflozin Efficacy and Safety Trial

Who this might be right for
Type 2 Diabetes Mellitus
Theracos 1,700
Post-approval studies (Phase 4)Not Yet RecruitingNCT06660940
What this trial is testing

Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy

Who this might be right for
Diabetic Kidney DiseaseDiabetic Retinopathy
Chinese PLA General Hospital 460
Large-scale testing (Phase 3)Study completedNCT01289990
What this trial is testing

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 2,705
Large-scale testing (Phase 3)Study completedNCT05801627
What this trial is testing

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Shenzhen Salubris Pharmaceuticals Co., Ltd. 408
Next Page